316 related articles for article (PubMed ID: 28645934)
1. Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time.
Hijazi Z; Lindahl B; Oldgren J; Andersson U; Lindbäck J; Granger CB; Alexander JH; Gersh BJ; Hanna M; Harjola VP; Hylek EM; Lopes RD; Siegbahn A; Wallentin L
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645934
[TBL] [Abstract][Full Text] [Related]
2. Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation.
Oldgren J; Hijazi Z; Lindbäck J; Alexander JH; Connolly SJ; Eikelboom JW; Ezekowitz MD; Granger CB; Hylek EM; Lopes RD; Siegbahn A; Yusuf S; Wallentin L;
Circulation; 2016 Nov; 134(22):1697-1707. PubMed ID: 27569438
[TBL] [Abstract][Full Text] [Related]
3. Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation.
Sharma A; Hijazi Z; Andersson U; Al-Khatib SM; Lopes RD; Alexander JH; Held C; Hylek EM; Leonardi S; Hanna M; Ezekowitz JA; Siegbahn A; Granger CB; Wallentin L
Circulation; 2018 Oct; 138(16):1666-1676. PubMed ID: 29871978
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA
Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Lip GYH; Marín F
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28729407
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE - LY Trial.
Hijazi Z; Verdecchia P; Oldgren J; Andersson U; Reboldi G; Di Pasquale G; Mazzotta G; Angeli F; Eikelboom JW; Ezekowitz MD; Connolly SJ; Yusuf S; Wallentin L
J Am Heart Assoc; 2019 Jan; 8(2):e010107. PubMed ID: 30651032
[TBL] [Abstract][Full Text] [Related]
6. Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Wallentin L; Hijazi Z; Andersson U; Alexander JH; De Caterina R; Hanna M; Horowitz JD; Hylek EM; Lopes RD; Asberg S; Granger CB; Siegbahn A;
Circulation; 2014 Nov; 130(21):1847-58. PubMed ID: 25294786
[TBL] [Abstract][Full Text] [Related]
7. Biomarker-Based Risk Prediction With the ABC-AF Scores in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation.
Benz AP; Hijazi Z; Lindbäck J; Connolly SJ; Eikelboom JW; Oldgren J; Siegbahn A; Wallentin L
Circulation; 2021 May; 143(19):1863-1873. PubMed ID: 33849281
[TBL] [Abstract][Full Text] [Related]
8. A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score.
Hijazi Z; Oldgren J; Lindbäck J; Alexander JH; Connolly SJ; Eikelboom JW; Ezekowitz MD; Held C; Hylek EM; Lopes RD; Yusuf S; Granger CB; Siegbahn A; Wallentin L;
Eur Heart J; 2018 Feb; 39(6):477-485. PubMed ID: 29069359
[TBL] [Abstract][Full Text] [Related]
9. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
[TBL] [Abstract][Full Text] [Related]
10. Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudy.
Hijazi Z; Oldgren J; Andersson U; Connolly SJ; Ezekowitz MD; Hohnloser SH; Reilly PA; Siegbahn A; Yusuf S; Wallentin L
Heart; 2014 Aug; 100(15):1193-200. PubMed ID: 24794140
[TBL] [Abstract][Full Text] [Related]
11. Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial.
Røsjø H; Hijazi Z; Omland T; Westerbergh J; Lyngbakken MN; Alexander JH; Gersh BJ; Granger CB; Hylek EM; Lopes RD; Siegbahn A; Wallentin L
J Intern Med; 2020 Aug; 288(2):248-259. PubMed ID: 32350915
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy.
Hijazi Z; Siegbahn A; Andersson U; Lindahl B; Granger CB; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz J; Husted S; Hylek EM; Lopes RD; McMurray JJ; Wallentin L
Clin Chem; 2015 Feb; 61(2):368-78. PubMed ID: 25451868
[TBL] [Abstract][Full Text] [Related]
13. High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Hijazi Z; Siegbahn A; Andersson U; Granger CB; Alexander JH; Atar D; Gersh BJ; Mohan P; Harjola VP; Horowitz J; Husted S; Hylek EM; Lopes RD; McMurray JJ; Wallentin L;
Circulation; 2014 Feb; 129(6):625-34. PubMed ID: 24226808
[TBL] [Abstract][Full Text] [Related]
14. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz JD; Husted S; Hylek EM; Lopes RD; McMurray JJ; Granger CB;
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):52-61. PubMed ID: 24055845
[TBL] [Abstract][Full Text] [Related]
15. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.
Hijazi Z; Oldgren J; Lindbäck J; Alexander JH; Connolly SJ; Eikelboom JW; Ezekowitz MD; Held C; Hylek EM; Lopes RD; Siegbahn A; Yusuf S; Granger CB; Wallentin L;
Lancet; 2016 Jun; 387(10035):2302-2311. PubMed ID: 27056738
[TBL] [Abstract][Full Text] [Related]
16. The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation.
Hijazi Z; Lindbäck J; Alexander JH; Hanna M; Held C; Hylek EM; Lopes RD; Oldgren J; Siegbahn A; Stewart RA; White HD; Granger CB; Wallentin L;
Eur Heart J; 2016 May; 37(20):1582-90. PubMed ID: 26920728
[TBL] [Abstract][Full Text] [Related]
17. Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48.
Berg DD; Ruff CT; Jarolim P; Giugliano RP; Nordio F; Lanz HJ; Mercuri MF; Antman EM; Braunwald E; Morrow DA
Circulation; 2019 Feb; 139(6):760-771. PubMed ID: 30586727
[TBL] [Abstract][Full Text] [Related]
18. Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores.
Rivera-Caravaca JM; Marín F; Vilchez JA; Gálvez J; Esteve-Pastor MA; Vicente V; Lip GYH; Roldán V
Stroke; 2019 Jun; 50(6):1372-1379. PubMed ID: 31084333
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
Bahit MC; Sacco RL; Easton JD; Meyerhoff J; Cronin L; Kleine E; Grauer C; Brueckmann M; Diener HC; Lopes RD; Brainin M; Lyrer P; Wachter R; Segura T; Granger CB;
Circulation; 2021 Nov; 144(22):1738-1746. PubMed ID: 34649459
[TBL] [Abstract][Full Text] [Related]
20. Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study.
Xiao J; Persson AP; Engström G; Johnson LSB
BMC Cardiovasc Disord; 2021 Mar; 21(1):134. PubMed ID: 33711943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
